Cholinergic Agonists & Antagonists Flashcards

1
Q

Muscarinic Agonist Prototype

A

Acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acetylcholine - Pharmacokinetics

A

(+) charge, does not cross BBB
short duration of action
non-selective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acetylcholine effects on vascular system

A

vasodilation - stimulate M3 receptors on vascular endothelium, releases NO, diffuses into vascular smooth muscle cells, causing relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Acetylcholine effects on cardiac system

A

(-) chronotropic effect (m2 mediated)
(-) inotropic effect (calcium mediated)
(-) conduction velocity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In the presence of atropine, ACh-induced stimulation of sympathetic ganglia can be observed as…

A

atropine selectively inhibits muscarinic receptors, so we see vasoconstriction and increased HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Effect of ACh for ophthalmic use

A

produces rapid and complete miosis

ciliary muscle contraction –> open trabecular meshwork –> increase aqueous humor to reduce IOP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acetylcholine (drug) adverse effects

A

bradycardia, hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

General properties of all synthetic choline esters/cholinomimetic alkaloids

A

more selective and prolonged action than ACh
esters do NOT cross BBB, alkaloids do
used for bladder disorders, xerostomia, and diagnosis of bronchial hyperreactivity, and ophthalmic indications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the prototype ester?

A

bethanechol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is the action of bethanechol prolonged (compared to ACh)?

A

resistant to hydrolysis by cholinersterases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bethanechol effect on smooth muscle

A

increases contraction of bladder and GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bethanechol - Therapeutic Uses

A

postop and postpartum urinary retention

GERD and gastric atony

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The two types of esters

A

Bethanechol - prototype

methacholine - other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Prototype Alkaloid

A

Pilocarpine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Action of Pilocarpine

A

partial agonist of all muscarinic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pilocarpine - Admin/Use

A

topical admin - miosis and blurred vision of distant objects, and fall in IOP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pilocarpine - therapeutic uses

A

xerostomia

wide-angle glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Alkaloid, selective M3 agonist

A

Cevimeline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cevimeline affinity for cardiac M2 receptors

A

low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cevimeline is usually prescribed for…

A

Sjogren’s Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Longer duration and fewer side-effects, pilocarpine or cevimeline?

A

Cevimeline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Toxicity indications for muscarinic agonists

A

sweating
hypotension
GI effects

23
Q

Contraindications for muscarinic agonists

A

hyperthyroidism
asthma
peptic ulcer

24
Q

Muscarinic agonist antidotes

A

atropine

epinephrine

25
Q

Muscarinic Antagonist Prototype

A

atropine

26
Q

Chemical classification of atropine

A

belladonna alkaloid

27
Q

Atropine - MOA

A

competitive blockade of muscarinic receptors

  • produces opposing effect of muscarinic receptor
  • super high doses –> nicotinic blockade too
  • no muscarinic selectivity
28
Q

Atropine - Pharmacokinetics

A

cross BBB

blocks receptors in blood vessels, sweat glands, and CNS

29
Q

Tissue Response is oral dose-dependent

A

Very low dose - salivary & bronchial secretions suppressed
low dose - mydriasis, cycloplegia, tachycardia
medium - tone/motility of GI tract and bladder reduced
high - gastric acid secretions partially reduced

30
Q

Atropine - CNS effects

A

low dose - mild excitation

toxic dose - hallucinations, delirium resembling psychosis

31
Q

Atropine - Ocular effects

A

mydriasis - photophobia

cycloplegia - blurred near vision

32
Q

Atropine - CV effects

A

heart - tachy, result of blocking vagal impulses

circulation - no effect @ normal dose, flushing reaction

33
Q

Atropine - respiratory effects

A

decreased bronchial secretions

relaxed bronchial smooth muscle

34
Q

Atropine - GI effects

A

inhibit salivation
reduced tone/motility
partial reduction in gastric acid secretion

35
Q

Atropine - therapeutic use

A

pre-op: reduce secretions
brady/AV block: cardiac resuscitation
mydriasis/cycloplegia (but, long duration of action)
AChE inhibitor poisoning: muscarinic effects

36
Q

Atropine - Adverse effects

A

dry mouth, blurred vision, photophobia, tachy, GI distress, hot/dry skin, urinary retention, confusion

37
Q

Atropine - Contraindication

A

prostatic hypertrophy and narrow-angle glaucoma

38
Q

Atropine - antidote

A

physostigmine: elevates synaptic concentration of agonist ACh

39
Q

Scopolamine

A

muscarinic antagonist

40
Q

Scopolamine - CNS penetrance

A

scopolamine better at CNS penetration than atropine

41
Q

Scopolamine - uses

A

sedative with euphoric effects

suppress emesis/motion sickness, blocks M receptors in vestibular apparatus

42
Q

Scopolamine - admin route

A

transdermal

43
Q

Ipratropium bromide drug classification

A

muscarinic antagonist

44
Q

Ipratropium bromide - characteristics

A

quaternary amine

dose NOT cross BBB

45
Q

Ipratropium bromide - therapeutic use

A

bronchodilator for COPD/asthma

46
Q

ipratropium bromide - admin route

A

inhalation, therefore minimal systemic effects

47
Q

Tropicamide - drug classification

A

muscarinic antagonist

48
Q

tropicamide - action

A

used for eye surgeries and causes mydriasis and cycloplegia (SHORT DURATION OF ACTION)

49
Q

Tolterodine - drug classification

A

muscarinic antagonist

50
Q

Tolterodine - receptor target & use

A

non-selective muscarinic antagonist

treats OAB

51
Q

Tolterodine - MOA

A

unclear…
believed to inhibit detrusor muscle contraction during filling
increase bladder capacity and decrease sensation of urgency (blocks basal release of ACh during bladder filling)

52
Q

Tolterodine - Efficacy

A

modest, takes up to 4 weeks to reach full efficacy

effective in ~30% of patients & anti-ACh side effects limit dose escalation

53
Q

What is a major concern associated with Tolterodine?

A

CNS-related anticholinergic effects, esp. problematic in cognitively-impaired geriatric patients